Benzinga | Aug 10, 2020 12:28PM EDT

UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $35

UBS maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $30 to $35.